ABOUT US

Senior Management

Wael Fayad

Chairman, President and Chief Executive Officer

Wael joined Enumeral in September 2016 as the company’s Chairman, President and Chief Executive Officer. Wael has more than two decades of senior executive and business development experience in the life sciences industry. From 2001 to 2014, he held positions of increasing responsibility at Forest Laboratories, Inc., culminating as Corporate Vice President, Global Business Development. In that role, he was responsible for business development and alliance management, including the identification, assessment and negotiation of multiple business opportunities. Wael helped build and manage a broad network of partnerships at Forest, and upon Forest’s acquisition by Actavis, he also assisted with the integration of the two companies. Wael was subsequently engaged in a number of entrepreneurial ventures, including helping to launch Valentine & Cautreels, Inc., a start-up company focusing on improving healthcare outcomes and reducing the total cost of care. He continues to serve on Valentine & Cautreels’ advisory board. Prior to Forest, Wael served in positions of increasing responsibility at Schering-Plough and Novartis in the fields of sales, marketing, and new product development. Wael holds a B.S. in biology from the American University of Beirut, and an M.B.A. from Concordia University.

Kevin Sarney

Vice President of Finance and Chief Accounting Officer

Kevin has been Vice President of Finance and Chief Accounting Officer since 2014. Previously, he was Vice President, Finance and Administration for Avaxia Biologics, a clinical-stage biopharmaceutical company developing gut-targeted therapeutics. Prior to joining Avaxia, he served from 2009 to 2013 at various biotechnology and medical device companies in interim Vice President of Finance and Controller roles. From 2005 to 2009, Kevin was the Corporate Controller and Principal Accounting Officer of NitroMed, a publicly traded cardiovascular-focused pharmaceutical company. Kevin earned a B.S. in business management from the University of Hartford, an M.B.A. from Boston University and an M.A. in accounting from Suffolk University. He is a certified public accountant in the Commonwealth of Massachusetts.

Matthew A. Ebert

General Counsel

Matt has served as Enumeral’s General Counsel since 2014, where he is responsible for the legal affairs of the company. Prior to Enumeral, Matt served as General Counsel at Stream Global Services, a multinational business process outsourcing company. Previously, he led the legal functions at several life sciences companies in Massachusetts, including as Deputy General Counsel, Secretary and Treasurer at NitroMed, a publicly-traded cardiovascular-focused pharmaceutical company. Matt began his legal career at Hale and Dorr LLP (now WilmerHale LLP). Matt holds a J.D. from Boston College Law School, an M.B.A. from the Carroll Graduate School of Management at Boston College, and an A.B. from Georgetown University.